{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:07:34Z","timestamp":1790096854690,"version":"4.0.1"},"reference-count":54,"publisher":"Elsevier","isbn-type":[{"value":"9780443470882","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.enz.2026.07.003","type":"book-chapter","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T14:06:26Z","timestamp":1786025186000},"page":"75-99","source":"Crossref","is-referenced-by-count":0,"title":["Classical MMP inhibitors"],"prefix":"10.1016","author":[{"given":"Andrea","family":"Trabocchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/bs.enz.2026.07.003_bib0001","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0092-8674(00)80429-8","article-title":"ECM and cell surface proteolysis: regulating cellular ecology","volume":"91","author":"Werb","year":"1997","journal-title":"Cell"},{"issue":"5","key":"10.1016\/bs.enz.2026.07.003_bib0002","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/0955-0674(95)80116-2","article-title":"Proteolytic remodeling of extracellular matrix","volume":"7","author":"Birkedal-Hansen","year":"1995","journal-title":"Curr. Opin. Cell Biol."},{"issue":"4","key":"10.1016\/bs.enz.2026.07.003_bib0003","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1357-4310(00)01686-5","article-title":"Matrix metalloproteinases: multifunctional contributors to tumor progression","volume":"6","author":"McCawley","year":"2000","journal-title":"Mol. Med. Today"},{"issue":"14","key":"10.1016\/bs.enz.2026.07.003_bib0004","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2174\/092986708784567680","article-title":"Progress in the development of matrix metalloproteinase inhibitors","volume":"15","author":"Tu","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/bs.enz.2026.07.003_bib0005","doi-asserted-by":"crossref","first-page":"10079","DOI":"10.1074\/jbc.271.17.10079","article-title":"The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases","volume":"271","author":"Whitelock","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2026.07.003_bib0006","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/jnci\/89.17.1260","article-title":"Changing views of the role of matrix metalloproteinases in metastasis","volume":"89","author":"Chambers","year":"1997","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/bs.enz.2026.07.003_bib0007","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/res.90.3.251","article-title":"Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly","volume":"90","author":"Galis","year":"2002","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/bs.enz.2026.07.003_bib0008","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry","volume":"92","author":"Visse","year":"2003","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/bs.enz.2026.07.003_bib0009","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/01.ATV.0000100402.69997.C3","article-title":"Matrix metalloproteinase-2 and -9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization","volume":"24","author":"Johnson","year":"2004","journal-title":"Arter. Thromb. Vasc. Biol."},{"issue":"33","key":"10.1016\/bs.enz.2026.07.003_bib0010","doi-asserted-by":"crossref","first-page":"20479","DOI":"10.1074\/jbc.272.33.20479","article-title":"Preparation and characterization of recombinant tissue inhibitor of metalloproteinase 4 (TIMP-4)","volume":"272","author":"Liu","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/bs.enz.2026.07.003_bib0011","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.bcp.2007.07.004","article-title":"Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease","volume":"75","author":"Raffetto","year":"2008","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/bs.enz.2026.07.003_bib0012","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bbamcr.2009.04.003","article-title":"Matrix metalloproteinases: fold and function of their catalytic domains","volume":"1803","author":"Tallant","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"45","key":"10.1016\/bs.enz.2026.07.003_bib0013","doi-asserted-by":"crossref","first-page":"9697","DOI":"10.1021\/acs.jpcb.3c04293","article-title":"Catalytic mechanism of collagen hydrolysis by zinc(II)-dependent matrix metalloproteinase-1","volume":"127","author":"Varghese","year":"2023","journal-title":"J. Phys. Chem. B"},{"issue":"22","key":"10.1016\/bs.enz.2026.07.003_bib0014","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.2174\/092986708785747490","article-title":"Structural bases for substrate and inhibitor recognition by matrix metalloproteinases","volume":"15","author":"Aureli","year":"2008","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/bs.enz.2026.07.003_bib0015","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.drudis.2019.07.013","article-title":"Understanding the variability of the S1\u2032 pocket to improve matrix metalloproteinase inhibitor selectivity profiles","volume":"25","author":"Gimeno","year":"2020","journal-title":"Drug Discov. Today"},{"issue":"6","key":"10.1016\/bs.enz.2026.07.003_bib0016","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nrd2308","article-title":"Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases","volume":"6","author":"Hu","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/bs.enz.2026.07.003_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107465","article-title":"The past, present and future perspectives of matrix metalloproteinase inhibitors","volume":"207","author":"Li","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"12","key":"10.1016\/bs.enz.2026.07.003_bib0018","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nrd4390","article-title":"Is there new hope for therapeutic matrix metalloproteinase inhibition?","volume":"13","author":"Vandenbroucke","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/bs.enz.2026.07.003_bib0019","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1021\/ar00153a003","article-title":"Structural basis of the action of thermolysin and related zinc peptidases","volume":"21","author":"Matthews","year":"1988","journal-title":"Acc. Chem. Res."},{"issue":"9","key":"10.1016\/bs.enz.2026.07.003_bib0020","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3390\/cells8090984","article-title":"The rebirth of matrix metalloproteinase inhibitors: moving beyond the dogma","volume":"8","author":"Fields","year":"2019","journal-title":"Cells"},{"key":"10.1016\/bs.enz.2026.07.003_bib0021","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1749-6632.1999.tb07673.x","article-title":"The next generation of MMP inhibitors. Design and synthesis","volume":"878","author":"De","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"9","key":"10.1016\/bs.enz.2026.07.003_bib0022","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1021\/cr9804543","article-title":"Design and therapeutic application of matrix metalloproteinase inhibitors","volume":"99","author":"Whittaker","year":"1999","journal-title":"Chem. Rev."},{"issue":"4","key":"10.1016\/bs.enz.2026.07.003_bib0023","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2174\/0929867013373417","article-title":"The design, structure, and therapeutic application of matrix metalloproteinase inhibitors","volume":"8","author":"Skiles","year":"2001","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/bs.enz.2026.07.003_bib0024","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbamcr.2009.08.006","article-title":"To bind zinc or not to bind zinc: an examination of innovative approaches to improved metalloproteinase inhibition","volume":"1803","author":"Jacobsen","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"15\u201316","key":"10.1016\/bs.enz.2026.07.003_bib0025","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.drudis.2007.06.003","article-title":"Insight into the structural determinants for selective inhibition of matrix metalloproteinases","volume":"12","author":"Pirard","year":"2007","journal-title":"Drug Discov. Today"},{"issue":"4","key":"10.1016\/bs.enz.2026.07.003_bib0026","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s000180050320","article-title":"Structural properties of matrix metalloproteinases","volume":"55","author":"Bode","year":"1999","journal-title":"Cell Mol. Life Sci."},{"issue":"7","key":"10.1016\/bs.enz.2026.07.003_bib0027","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1021\/cr030448t","article-title":"Quantitative structure-activity relationship studies on zinc-containing metalloproteinase inhibitors","volume":"107","author":"Gupta","year":"2007","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/bs.enz.2026.07.003_bib0028","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10555-006-7894-9","article-title":"Recent advances in MMP inhibitor design","volume":"25","author":"Fisher","year":"2006","journal-title":"Cancer Metastasis Rev."},{"issue":"14","key":"10.1016\/bs.enz.2026.07.003_bib0029","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1073\/pnas.87.14.5578","article-title":"The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family","volume":"87","author":"Van Wart","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/bs.enz.2026.07.003_bib0030","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2174\/1381612053382115","article-title":"Recent developments in the design of specific Matrix Metalloproteinase inhibitors aided by structural and computational studies","volume":"11","author":"Rao","year":"2005","journal-title":"Curr. Pharm. Des."},{"issue":"5564","key":"10.1016\/bs.enz.2026.07.003_bib0031","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1126\/science.1067100","article-title":"Matrix metalloproteinase inhibitors and cancer: trials and tribulations","volume":"295","author":"Coussens","year":"2002","journal-title":"Science"},{"issue":"13","key":"10.1016\/bs.enz.2026.07.003_bib0032","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1021\/jm9700474","article-title":"Structure-activity relationships of N-hydroxyurea 5-lipoxygenase inhibitors","volume":"40","author":"Stewart","year":"1997","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/bs.enz.2026.07.003_bib0033","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.biochi.2010.07.017","article-title":"Third generation of matrix metalloprotease inhibitors: gain in selectivity by targeting the depth of the S1\u2032 cavity","volume":"92","author":"Devel","year":"2010","journal-title":"Biochimie"},{"issue":"26","key":"10.1016\/bs.enz.2026.07.003_bib0034","doi-asserted-by":"crossref","first-page":"10792","DOI":"10.1021\/jo0517848","article-title":"Squaric acid-based peptidic inhibitors of matrix metalloprotease-1","volume":"70","author":"Onaran","year":"2005","journal-title":"J. Org. Chem."},{"key":"10.1016\/bs.enz.2026.07.003_bib0035","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1749-6632.1999.tb07689.x","article-title":"Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials","volume":"878","author":"Shalinsky","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3","key":"10.1016\/bs.enz.2026.07.003_bib0036","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1158\/1078-0432.CCR-0981-3","article-title":"Phase I and pharmacokinetic study of prinomastat, a matrix metalloprotease inhibitor","volume":"10","author":"Hande","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/bs.enz.2026.07.003_bib0037","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/sj.bjc.6603043","article-title":"Towards third generation matrix metalloproteinase inhibitors for cancer therapy","volume":"94","author":"Overall","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/bs.enz.2026.07.003_bib0038","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbamcr.2009.04.010","article-title":"Structural and functional bases for allosteric control of MMP activities: can it pave the path for selective inhibition?","volume":"1803","author":"Sela-Passwell","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"20","key":"10.1016\/bs.enz.2026.07.003_bib0039","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.2174\/138161207781039706","article-title":"Matrix metalloproteinase inhibitors: new challenges in the era of post broad-spectrum inhibitors","volume":"13","author":"Nuti","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/bs.enz.2026.07.003_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.impact.2021.100293","article-title":"Matrix metalloproteinase inhibitors (MMPIs) as attractive therapeutic targets: recent progress and current challenges","volume":"21","author":"Shi","year":"2021","journal-title":"NanoImpact"},{"issue":"7","key":"10.1016\/bs.enz.2026.07.003_bib0041","first-page":"1207","article-title":"The matrix metalloproteinase inhibitor batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice","volume":"2","author":"Low","year":"1996","journal-title":"Clin. Cancer Res."},{"issue":"31","key":"10.1016\/bs.enz.2026.07.003_bib0042","doi-asserted-by":"crossref","first-page":"7152","DOI":"10.1021\/bi00146a017","article-title":"Inhibition of human skin fibroblast collagenase, thermolysin, and Pseudomonas aeruginosa elastase by peptide hydroxamic acids","volume":"31","author":"Grobelny","year":"1992","journal-title":"Biochemistry"},{"issue":"43","key":"10.1016\/bs.enz.2026.07.003_bib0043","doi-asserted-by":"crossref","first-page":"14012","DOI":"10.1021\/bi00043a007","article-title":"Structure determination and analysis of human neutrophil collagenase complexed with a hydroxamate inhibitor","volume":"34","author":"Grams","year":"1995","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/bs.enz.2026.07.003_bib0044","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00210790","article-title":"Phase I trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancer","volume":"14","author":"Wojtowicz-Praga","year":"1996","journal-title":"Invest. New Drugs"},{"issue":"6","key":"10.1016\/bs.enz.2026.07.003_bib0045","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0748-7983(97)93077-8","article-title":"Phase I\/II trial of batimastat, a matrix metalloproteinase inhibitor, in patients with malignant ascites","volume":"23","author":"Parsons","year":"1997","journal-title":"Eur. J. Surg. Oncol."},{"issue":"36","key":"10.1016\/bs.enz.2026.07.003_bib0046","doi-asserted-by":"crossref","first-page":"24185","DOI":"10.1074\/jbc.M109.029116","article-title":"Structural and inhibition analysis reveals the mechanism of selectivity of a series of aggrecanase inhibitors","volume":"284","author":"Tortorella","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/bs.enz.2026.07.003_bib0047","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1021\/jm960871c","article-title":"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits","volume":"40","author":"MacPherson","year":"1997","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/bs.enz.2026.07.003_bib0048","first-page":"1912","article-title":"Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer","volume":"7","author":"Levitt","year":"2001","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/bs.enz.2026.07.003_bib0049","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s10585-008-9198-7","article-title":"Matrix metalloproteinase inhibitor, MMI270 (CGS27023A) inhibited hematogenic metastasis of B16 melanoma cells in both experimental and spontaneous metastasis models","volume":"25","author":"Kasaoka","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"issue":"11","key":"10.1016\/bs.enz.2026.07.003_bib0050","first-page":"3603","article-title":"BAY 12-9566, a novel inhibitor of matrix metalloproteinases with antiangiogenic activity","volume":"5","author":"Gatto","year":"1999","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/bs.enz.2026.07.003_bib0051","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1517\/13543784.9.9.2159","article-title":"Prinomastat, a hydroxamate-based matrix metalloproteinase inhibitor. A novel pharmacological approach for tissue remodelling-related diseases","volume":"9","author":"Scatena","year":"2000","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"4","key":"10.1016\/bs.enz.2026.07.003_bib0052","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1200\/JCO.2005.03.170","article-title":"Phase III study of matrix metalloproteinase inhibitor prinomastat in non-small-cell lung cancer","volume":"23","author":"Bissett","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/bs.enz.2026.07.003_bib0053","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.phrs.2010.12.003","article-title":"Clinical studies on the management of periodontal diseases utilizing subantimicrobial dose doxycycline (SDD)","volume":"63","author":"Caton","year":"2011","journal-title":"Pharmacol. Res."},{"issue":"8","key":"10.1016\/bs.enz.2026.07.003_bib0054","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1902\/jop.2004.75.8.1068","article-title":"Subantimicrobial dose doxycycline enhances the efficacy of scaling and root planing in chronic periodontitis: a multicenter trial","volume":"75","author":"Preshaw","year":"2004","journal-title":"J. Periodontol."}],"container-title":["The Enzymes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874604726000338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874604726000338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:11:36Z","timestamp":1790093496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1874604726000338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443470882"],"references-count":54,"URL":"https:\/\/doi.org\/10.1016\/bs.enz.2026.07.003","relation":{},"ISSN":["1874-6047"],"issn-type":[{"value":"1874-6047","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}